BCL3 and nasopharyngeal carcinoma: However, when the expression of BCL3 among NPC, MGUS, SMM, and MM subgroups was compared, the level of BCL3 was significantly increased in one of the gene expression-defined high-risk subgroups, namely the PR (proliferation) subgroup (Fig. 2A) (28).